Manufacturing and R&D update for COVID-19 test

Paris, France and Camberley, UK – 15 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides a manufacturing, and research and development update on its polymerase chain reaction (PCR) test for COVID-19, developed by Primerdesign, the Company’s molecular diagnostics division based in the UK.

https://novacyt.com/wp-content/uploads/2020/04/Novacyt-COVID-19-test-update-ENGLISH-15.4.20.pdf